Evidence map›Paper›PMID 25600668›Full record

ArticleEpidemiology and infection2015

Seroepidemiology of Toxoplasma in a coastal region of Haiti: multiplex bead assay detection of immunoglobulin G antibodies that recognize the SAG2A antigen.

J W Priest, D M Moss, B F Arnold, K Hamlin, C C Jones, P J Lammie

Abstract read
In one paragraph

Article in Epidemiology and infection, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Detection of Anti-Analytical chemistry · 2019
    Article
  10. Article
  11. Characterizing Reactivity toThe American journal of tropical medicine and hygiene · 2017
    Article
  12. Evaluation of Immunoglobulin G Responses toThe American journal of tropical medicine and hygiene · 2017
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

J W PriestDivision of Foodborne, Waterborne, and Environmental Diseases,Centers for Disease Control and Prevention,Atlanta, GA,USA.
D M MossDivision of Foodborne, Waterborne, and Environmental Diseases,Centers for Disease Control and Prevention,Atlanta, GA,USA.
B F ArnoldDivision of Epidemiology, School of Public Health,University of California,Berkeley, CA,USA.
K HamlinDivision of Parasitic Diseases and Malaria,Centers for Disease Control and Prevention,Atlanta, GA,USA.
C C JonesDivision of Parasitic Diseases and Malaria,Centers for Disease Control and Prevention,Atlanta, GA,USA.
P J LammieDivision of Parasitic Diseases and Malaria,Centers for Disease Control and Prevention,Atlanta, GA,USA.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Toxoplasma gondii is a globally distributed parasitic protozoan that infects most warm-blooded animals. We incorporated a bead coupled with recombinant SAG2A protein into our Neglected Tropical Disease (NTD) multiplex bead assay (MBA) panel and used it to determine Toxoplasma infection rates in two studies in Haiti. In a longitudinal cohort study of children aged 0-11 years, the infection rate varied with age reaching a maximum of 0·131 infections/year in children aged 3 years [95% confidence interval (CI) 0·065-0·204]. The median time to seroconversion was estimated to be 9·7 years (95% CI 7·6-∞). In a cross-sectional, community-wide survey of residents of all ages, we determined an overall seroprevalence of 28·2%. The seroprevalence age curve from the cross-sectional study also suggested that the force of infection varied with age and peaked at 0·057 infections/year (95% CI 0·033-0·080) at age 2·6 years. Integration of the Toxoplasma MBA into NTD surveys may allow for better estimates of the potential burden of congenital toxoplasmosis in underserved regions.

Indexed as

Antigens, ProtozoanProtozoan ProteinsAge FactorsAnimalsAntibodies, ProtozoanChildChild, PreschoolCohort StudiesCross-Sectional StudiesFemaleHaitiHumansImmunoassayImmunoglobulin GInfantInfant, NewbornAntibodies, ProtozoanAntigens, ProtozoanImmunoglobulin GProtozoan Proteinssurface antigen P22, ToxoplasmaAntibodyHaitiimmunodominantinfectionLuminexToxoplasma

Identifiers

PMID25600668
PMCPMC5844480

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.